Carillon Mitral Contour System® for Reducing Functional Mitral Regurgitation
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 163 participants.
Also called NCT02325830
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 163 participants
- Sponsor
- Cardiac Dimensions Pty Ltd
- Registry
-
NCT02325830
-
- Other papers using this trial's data
- The REDUCE FMR Trial: A Randomized Sham-Controlled Study of Percutaneous Mitral Annuloplasty in Functional Mitral Regurgitation
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Australia, Czechia, France, Germany, Netherlands, New Zealand, Poland, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT02325830. Randomized; double masking; primary purpose treatment. Start 2015-08-22 (actual); primary completion 2018-07-01 (actual). Results posted on 2024-08-05.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Carillon Mitral Contour System® for Reducing Functional Mitral Regurgitation
- Acronym
- REDUCE FMR
- Condition
- Mitral Valve Insufficiency
- Condition
- Heart Failure
- Intervention (Device)
- Carillon Mitral Contour System
- Lead sponsor
- Cardiac Dimensions Pty Ltd
- Collaborator
- Menzies Institute for Medical Research
Record details
- Record id
cardio:ct-nct02325830- Content hash
0b6962ea1789558a601eb38edf7ff5877b199825eef8ad68ff6db098691a684e